Journals / MN Kardiyoloji / 2014 / Cilt: 21 - Sayı: 2

Knowledge and awareness of ambulatory prothrombin time monitoring systems the results of questionnaire study

Ambulatuvar protrombin zamanı monitör sistemlerinin bilinirliği: Anket çalışması sonuçları

Pages
74–79
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Utilization of the device could be increased by informing physicians and patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To evaluate knowledge and awareness of ambulatory prothrombin time monitoring systems among the physicians and the patients who received warfarin.
📊
Key Findings & Data:The research was rendered with 104 patients under vitamin K antagonists and 376 physicians consisted of cardiologists, cardiovascular surgeons and neurologists.
💡
Conclusion & Impact:Utilization of the device could be increased by informing physicians and patients.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To evaluate knowledge and awareness of ambulatory prothrombin time monitoring systems among the physicians and the patients who received warfarin. Material and Method: An anonymous questionnaire was applied to physicians and patients who received the therapy more than six months. Stratified random sampling as a method of sampling was used. The research was rendered with 104 patients under vitamin K antagonists and 376 physicians consisted of cardiologists, cardiovascular surgeons and neurologists. Results: The awareness of ambulatory prothrombin time monitoring systems was 35% among the physicians. If they had any knowledge, 35% of them would have advised those systems to their patients. Although 35% of the physicians had heard of ambulatory prothrombin time monitoring systems 13% of them had informed to patients about that device. The awareness of ambulatory prothrombin time monitoring systems was 8% among patients and only 1% of the patients had used portable devices. Conclusion: Both the physician’s and the patient’s knowledge and awareness about ambulatory prothrombin time monitoring sys- tems was poor. Utilization of the device could be increased by informing physicians and patients.

Özet

Amaç: Doktorlar ve hastalar arasında taşınabilir INR ölçüm cihazlarının bilinirliliğini değerlendirmektir. Gereç ve Yöntem: Altı aydan uzun süredir OAK tedavi kullanan hastalar ve doktorlara anket uygulandı. Tabakalı rastgele örnekleme yöntemi kullanıldı. Araştırmaya OAK kullanan 104 hasta ve kardiyolog, nörolog, kardiyovasküler cerrahtan oluşan 376 doktor dahil edildi. Bulgular: Hastaların sadece %8’inin taşınabilir ölçüm cihazları hakkında bilgi sahibi olduğu saptandı ve %1 hastanın taşınabilir ölçüm cihazı kullandığı belirlendi. Doktorların %13’ünün hastalarına taşınabilir ölçüm cihazı hakkında bilgi verdiği belirlendi. Sonuç: Hem hastaların hem doktorların taşınabilir INR ölçüm cihazları hakkında bilgilerinin yetersiz olduğu belirlendi. Doktor ve hastalar bilgilendirilerek kullanım oranı artırılabilir.

🔖

Cite This Article

ŞEN, F., YILMAZ, S., TEMİZHAN, A. (2014). Knowledge and awareness of ambulatory prothrombin time monitoring systems the results of questionnaire study. MN Kardiyoloji, Cilt: 21 - Sayı: 2, 74–79. https://ajindex.com/articles/297317

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hirsh J. Dalen JE. Anderson DR. et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119(1):8-21
  2. Niederer A. Wuillemin WA. de Moerloose P. Orale Antikoagulation: Praktisches Vorgehen. Schweiz Med Forum 2001;17(1):425-30
  3. Wuillemin WA. Burri S. La ̈mmle B. Quick-Messung aus Kapillar-Blut mittels CoaguChekR oder CoaguChekR Plus. Labolife 1997;3(1):9-12
  4. Machin SJ. Mackie IJ. Chitolie A. Lawrie AS. Near patient testing (NPT) in haemostasis - a synoptic review. Clin Lab Haematol 1996;18:69-74
  5. Shiach CR. Campbell B. Poller L. Keown M. Chauhan N. Reliability of point-of-care prothrombin time testing in a community clinic: a randomized crossover comparison with hospital laboratory testing. Br J Haematol 2002; 119:370-5
  6. Heneghan C. Alonso-Coello P. Garcia-Alamino JM. Perera R. Meats E. Glasziou P. Self-monitoring of oral anticoagu- lation: a systematic review and meta-analysis. Lancet 2006;367:404-11
  7. Murray ET. Fitzmaurice DA. McCahonD. Point of care testing for INR monitoring: where are we now? Br J Haematol 2004;127:373-8
  8. Ryan F. Byrne S. O'Shea S. Managing oral anticoagulation therapy: improving clinical outcomes. A review. J Clin Pharm Ther 2008;33(6):581-90
  9. Murray ET. Greaves M. INRs and point of care testing. BMJ 2003;327:5-6
  10. Oberhardt BJ. Dermott SC. Taylor M. Alkadi ZY. Abruzzini AF. Gresalfi NJ. Dry reagent technology for rapid, conven- ient measurements of blood coagulation and fibrinolysis. Clin Chem 1991;37:520-6
  11. Rose VL. Dermott SC. Murray BF. McIver MM. High KA. Oberhardt BJ. Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable analyzer. Arch Pathol Lab Med 1993;117:611-7
  12. Jackson SL. Bereznicki LR. Peterson GM. et al. Accuracy and clinical usefulness ofthe near-patient testing CoaguChek S international normalised ratio monitor in rural medical practice. Aust J Rural Health 2004;12(4):137-42
  13. Medical Advisory Secretariat. Point-of-care international normalized ratio (INR) monitoring devices for patients on long-term oral anticoagulation therapy: an evidence- based analysis. Ont Health Techno Assess Se 2009; 9(12):1-114